BlackRock Japan’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$26.9M Buy
862,725
+6,933
+0.8% +$225K 0.09% 259
2016
Q3
$34.4M Sell
855,792
-303
-0% -$11.4K 0.12% 205
2016
Q2
$28.5M Buy
856,095
+42,168
+5% +$1.44M 0.1% 234
2016
Q1
$23.9M Buy
813,927
+7,029
+0.9% +$194K 0.09% 254
2015
Q4
$21.2M Sell
806,898
-211,512
-21% -$5.49M 0.08% 283
2015
Q3
$24.1M Sell
1,018,410
-176,730
-15% -$4.27M 0.1% 236
2015
Q2
$28.4M Buy
1,195,140
+295,584
+33% +$6.67M 0.11% 211
2015
Q1
$21.4M Buy
899,556
+49,284
+6% +$1.11M 0.09% 273
2014
Q4
$18.1M Buy
850,272
+152,304
+22% +$3.06M 0.07% 324
2014
Q3
$11.9M Buy
697,968
+39,306
+6% +$620K 0.05% 402
2014
Q2
$9.42M Sell
658,662
-75,558
-10% -$1.02M 0.04% 466
2014
Q1
$9.08M Sell
734,220
-260,904
-26% -$3.01M 0.04% 498
2013
Q4
$10.9M Sell
995,124
-107,664
-10% -$1.21M 0.05% 436
2013
Q3
$12.8M Buy
1,102,788
+235,404
+27% +$2.75M 0.06% 368
2013
Q2
$9.71M Buy
+867,384
New +$10.3M 0.04% 453

Other funds holding EW

BlackRock Japan's EW Position: Q4 2016 in Review

BlackRock Japan increased its Edwards Lifesciences (EW) stake by 0.81% in Q4 2016, buying an estimated $225K and bringing the position to 862,725 shares worth $26.9M. The position accounts for 0.09% of the portfolio, ranked #259.

BlackRock Japan first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $34.4M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • BlackRock Japan held 862,725 shares of Edwards Lifesciences worth $26.9M as of Q4 2016.
  • BlackRock Japan bought 6,933 Edwards Lifesciences shares in Q4 2016, an estimated $225K.
  • Edwards Lifesciences made up 0.09% of BlackRock Japan's portfolio in Q4 2016, its #259 holding.
  • BlackRock Japan first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Japan's Edwards Lifesciences position peaked at $34.4M in Q3 2016.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.